{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:06:14Z","timestamp":1790744774304,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1523,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008081","name":"Dystrophic Epidermolysis Bullosa Research Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1038\/jid.2011.169","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T07:33:34Z","timestamp":1309419214000},"page":"2079-2086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Development of Allele-Specific Therapeutic siRNA for Keratin 5 Mutations in Epidermolysis Bullosa Simplex"],"prefix":"10.1016","volume":"131","author":[{"given":"Sarah D.","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E.","family":"McGilligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko","family":"Szeverenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances J.D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Tara Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Irwin McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2011.169_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000250096","article-title":"Epidermolysis bullosa herpetiformis Dowling-Meara. Report of a case and pathomorphogenesis","volume":"164","author":"Anton-Lamprecht","year":"1982","journal-title":"Dermatologica"},{"key":"10.1038\/jid.2011.169_bb0015","first-page":"926","article-title":"Allele-specific siRNA therapy for epidermolysis bullosa simplex","volume":"162","author":"Atkinson","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.169_bb0020","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.1720261","article-title":"Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities","volume":"254","author":"Bonifas","year":"1991","journal-title":"Science"},{"key":"10.1038\/jid.2011.169_bb0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1038\/jid.2011.169_bb0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1083\/jcb.152.3.651","article-title":"An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy","volume":"152","author":"Cao","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2011.169_bb0035","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.171251798","article-title":"Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems","volume":"98","author":"Caplen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.169_bb0040","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0092-8674(91)90051-Y","article-title":"Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analysis","volume":"66","author":"Coulombe","year":"1991","journal-title":"Cell"},{"key":"10.1038\/jid.2011.169_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2006.07.007","article-title":"Knocking down disease with siRNAs","volume":"126","author":"Dykxhoorn","year":"2006","journal-title":"Cell"},{"key":"10.1038\/jid.2011.169_bb0050","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1073\/pnas.0601309103","article-title":"Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism","volume":"103","author":"Dykxhoorn","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.169_bb0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1038\/jid.2011.169_bb0060","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","article-title":"The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB","volume":"58","author":"Fine","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2011.169_bb0065","doi-asserted-by":"crossref","first-page":"30248","DOI":"10.1074\/jbc.M109.045294","article-title":"Dominant-negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII","volume":"284","author":"Fritsch","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2011.169_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1196\/annals.1348.059","article-title":"SiRNA-mediated selective inhibition of mutant keratin mRNAs responsible for the skin disorder pachyonychia congenita","volume":"1082","author":"Hickerson","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/jid.2011.169_bb0075","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.jid.5701060","article-title":"Single-nucleotide-specific siRNA targeting in a dominant-negative skin model","volume":"128","author":"Hickerson","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.169_bb0080","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2133.1997.tb02141.x","article-title":"The prevalence of epidermolysis bullosa in Scotland","volume":"136","author":"Horn","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.169_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1098-1004(1996)8:1<57::AID-HUMU8>3.0.CO;2-M","article-title":"Three keratin gene mutations account for the majority of dominant simplex epidermolysis bullosa cases within the population of Ireland","volume":"8","author":"Humphries","year":"1996","journal-title":"Hum Mutat"},{"key":"10.1038\/jid.2011.169_bb0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1046\/j.1365-2133.1999.02810.x","article-title":"Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation","volume":"140","author":"Irvine","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.169_bb0095","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/1523-1747.ep12491885","article-title":"Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin filament network involving keratins K5 and K14","volume":"97","author":"Ishida-Yamamoto","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.169_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1523-1747.2002.19642.x","article-title":"Ribozyme therapeutics","volume":"7","author":"Kashani-Sabet","year":"2002","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2011.169_bb0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1087-0024.2005.10208.x","article-title":"Challenges in developing therapies for rare diseases including pachyonychia congenita","volume":"10","author":"Kaspar","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2011.169_bb0110","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/jid.2009.220","article-title":"Achieving successful delivery of nucleic acids to skin: 6th Annual Meeting of the International Pachyonychia Congenita Consortium","volume":"129","author":"Kaspar","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.169_bb0115","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.ddmec.2008.09.001","article-title":"Broken bricks and cracked mortar: epidermal diseases resulting from genetic abnormalities","volume":"5","author":"Lane","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1038\/jid.2011.169_bb0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/356244a0","article-title":"A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering","volume":"356","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"10.1038\/jid.2011.169_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2008.04.003","article-title":"Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita","volume":"51","author":"Leachman","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2011.169_bb0130","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2009.273","article-title":"First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder","volume":"18","author":"Leachman","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2011.169_bb0135","first-page":"S91","article-title":"Mutation-specific siRNA therapy for epidermolysis bullosa simplex","volume":"130","author":"McGilligan","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.169_bb0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1523-1747.2001.01279-11.x","article-title":"Epidermolysis bullosa carrier frequencies in the US population","volume":"116","author":"Pfendner","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.169_bb0145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/sj.jid.5700571","article-title":"Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations","volume":"127","author":"Rugg","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.169_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2133.2000.03304.x","article-title":"Laryngeal involvement in the Dowling-Meara variant of epidermolysis bullosa simplex with keratin mutations of severely disruptive potential","volume":"142","author":"Shemanko","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.169_bb0155","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0006-291X(02)02288-X","article-title":"Cloning of human, murine, and marsupial keratin 7 and a survey of K7 expression in the mouse","volume":"297","author":"Smith","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/jid.2011.169_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/humu.20652","article-title":"The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases","volume":"29","author":"Szeverenyi","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1038\/jid.2011.169_bb0165","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1093\/hmg\/ddq405","article-title":"K14 mRNA reprogramming for dominant epidermolysis bullosa simplex","volume":"19","author":"Wally","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/jid.2011.169_bb0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2003.12.098","article-title":"siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme","volume":"314","author":"Yokota","year":"2004","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15350430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15350430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T07:52:19Z","timestamp":1743925939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15350430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0022202X15350430"],"URL":"https:\/\/doi.org\/10.1038\/jid.2011.169","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13051956.14371054","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Allele-Specific Therapeutic siRNA for Keratin 5 Mutations in Epidermolysis Bullosa Simplex","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2011.169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}